Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Ron Weitzman"'
2
Abstract 3452: TNG908, a brain-penetrant MTA-cooperative PRMT5 inhibitor, is efficacious in preclinical glioblastoma models
Autor: Minjie Zhang, Alice Tsai, Kevin M. Cottrell, Brian B. Haines, Erik Wilker, Heather DiBenedetto, Ron Weitzman, Alan Huang, Charles B. Davis, John P. Maxwell, Kimberly J. Briggs
Publikováno v: Cancer Research. 83:3452-3452
Glioblastoma multiforme (GBM) is one of the most aggressive primary malignant brain tumors in adults. The median overall survival (OS) of GBM patients is poor (1-2 years) on standard of care therapies, which include surgery, radiotherapy, and the alk
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0ee6306d843655fbac7692ec315d14f1
https://doi.org/10.1158/1538-7445.am2023-3452
Zobrazit plný text záznamu
3
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma
Autor: Ron Weitzman, Davis C. Woodworth, Colin Hessel, Jaymes Holland, Patrick Y. Wen, Dana T. Aftab, Michael D. Prados, John de Groot, Ararat Chakhoyan, Catalina Raymond, Jan Drappatz, Jerry Ping, Annick Desjardins, Timothy F. Cloughesy, David Schiff, Gisela Schwab, Robert J. Harris, David A. Reardon, Marc C. Chamberlain, Kevin Leu, Benjamin M. Ellingson, Tom Mikkelsen
Publikováno v: Neuro-oncology, vol 20, iss 10
Ellingson, BM; Aftab, DT; Schwab, GM; Hessel, C; Harris, RJ; Woodworth, DC; et al.(2018). Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. NEURO-ONCOLOGY, 20(10), 1411-1418. doi: 10.1093/neuonc/noy054. UCLA: Retrieved from: http://www.escholarship.org/uc/item/66j537hb
Author(s): Ellingson, Benjamin M; Aftab, Dana T; Schwab, Gisela M; Hessel, Colin; Harris, Robert J; Woodworth, Davis C; Leu, Kevin; Chakhoyan, Ararat; Raymond, Catalina; Drappatz, Jan; de Groot, John; Prados, Michael D; Reardon, David A; Schiff, Davi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e942cf6800e34982972afb57108888b
https://pubmed.ncbi.nlm.nih.gov/29660005
Zobrazit plný text záznamu
4
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy
Autor: Patrick Y. Wen, Jaymes Holland, David A. Reardon, David Schiff, John de Groot, Marc C. Chamberlain, Tom Mikkelsen, Timothy F. Cloughesy, Jan Drappatz, Jerry Ping, Annick Desjardins, Michael D. Prados, Ron Weitzman
Publikováno v: Neuro-Oncology
Neuro-oncology, vol 20, iss 2
Author(s): Wen, Patrick Y; Drappatz, Jan; de Groot, John; Prados, Michael D; Reardon, David A; Schiff, David; Chamberlain, Marc; Mikkelsen, Tom; Desjardins, Annick; Holland, Jaymes; Ping, Jerry; Weitzman, Ron; Cloughesy, Timothy F | Abstract: Backgro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34ba1873b81b922836982d74711b1ebf
https://pubmed.ncbi.nlm.nih.gov/29016998
Zobrazit plný text záznamu
5
A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma
Autor: Jennifer J. Wheler, Razelle Kurzrock, Ron Weitzman, Yihua Lee, Ignace Vergote, Raanan Berger, Avishay Sella, David Smith, Ronald J. Buckanovich, Nicholas J. Vogelzang, Paul Foster
Background Cabozantinib (XL184), an orally bioavailable inhibitor of vascular endothelial growth factor receptor 2 and MET, was assessed in a cohort of ovarian carcinoma patients as part of a phase 2 randomised discontinuation trial (RDT) with cohort
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d2fb8dc930647750ab2661885055ca
https://lirias.kuleuven.be/handle/123456789/588645
Zobrazit plný text záznamu
6
A national study on lipid management
Autor: Anat Raskin Segal, Avi Porath, Alan Jotkowitz, Gad Rabinowitz, Ron Weitzman, Victor Novack
Publikováno v: European Journal of Internal Medicine. 19:356-361
Background Hyperlipidemia remains a major cause of morbidity in Western countries. The objective of this study was to document the percentage of adults who underwent periodical LDL measurement, and the percentage of patients with diabetes and post-an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afaecb40cd68a8efe74536be4dc1c647
https://doi.org/10.1016/j.ejim.2007.10.011
Zobrazit plný text záznamu
7
Sensitivity of 'Push' and 'Pull' strategies to information updating rate
Autor: Ron Weitzman, Gad Rabinowitz
Publikováno v: International Journal of Production Research. 41:2057-2074
One would expect a continuous production planning and control system to be more sensitive to information inaccuracy than a periodic one. In practice, a major source of information inaccuracy is the updating rate of the perceived system state. This ph
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca37fb88387ab1f426c66528234dfea7
https://doi.org/10.1080/0020754031000075862
Zobrazit plný text záznamu
8
Estimation of mortality savings due to a national program for diabetes care
Autor: Ron Weitzman, Gad Rabinowitz, Jacob Dreiher, Avi Porath, Anat Raskin-Segal, Gary M. Ginsberg
Publikováno v: European journal of internal medicine. 20(3)
Diabetes-related complications can be reduced by better control of glycemia, lipid abnormalities and blood pressure. In recent years, efforts at improving diabetes care in Israel have been made. This study aims to estimate mortality savings related t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7a639fdbe27e65a43f2d96c63470086
https://pubmed.ncbi.nlm.nih.gov/19393499
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje